Congenital ichthyosiform erythroderma in pregnancy: a case report of a retinoic acid embryopathy
Acta Obstétrica e Ginecológica Portuguesa · 2024
DOI: 10.69729/aogp.v18i2a07 ↗Kurz gefasst
Fallbericht in der Zeitschrift Acta Obstétrica e Ginecológica Portuguesa, 2024. Verfasst von Sara Forjaz und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Congenital ichthyosiform erythroderma (EHK) is a major cutaneous disease, autosomal dominant, usually present at birth. There is no curative treatment; in the most severe cases, the control of symptoms relies on oral retinoids. We present a case of a pregnant woman with EHK taking retinoids until the 33rd week of pregnancy. The woman delivered a newborn with multiple minor malformations, without cutaneous lesions, suggestive of retinoic acid embryopathy. This case highlights the importance of recognizing the teratogenicity of drugs in women of reproductive age. We describe a complex multidisciplinary approach and the obstetrical challenges in such a rare disease.
Zitieren
APA
Forjaz, S., Almendra, R., Braga, L., Monteiro, M. J., & Cardoso, L. (2024). Congenital ichthyosiform erythroderma in pregnancy: a case report of a retinoic acid embryopathy. Acta Obstétrica e Ginecológica Portuguesa. https://doi.org/10.69729/aogp.v18i2a07
Vancouver
Forjaz S, Almendra R, Braga L, Monteiro MJ, Cardoso L. Congenital ichthyosiform erythroderma in pregnancy: a case report of a retinoic acid embryopathy. Acta Obstétrica e Ginecológica Portuguesa. 2024. doi:10.69729/aogp.v18i2a07
BibTeX
@article{Forjaz2024,
author = {Forjaz, Sara and Almendra, Rita and Braga, Luís and Monteiro, Maria José and Cardoso, Luísa},
title = {Congenital ichthyosiform erythroderma in pregnancy: a case report of a retinoic acid embryopathy},
journal = {Acta Obstétrica e Ginecológica Portuguesa},
year = {2024},
doi = {10.69729/aogp.v18i2a07}
}
EUVIMED